Literature DB >> 2826668

Cloning and characterization of the gene encoding the major protein of the A-type inclusion body of cowpox virus.

S Funahashi1, T Sato, H Shida.   

Abstract

We have mapped and determined the nucleotide sequence of the cowpox virus (CPV) gene coding for the protein of A-type inclusion bodies (ATI). The ATI gene was mapped to the central part of the largest HindIII restriction fragment of the CPV genome. Vaccinia virus (VV) also contained a similar sequence at the equivalent position in its genome, which even under stringent conditions hybridized with the CPV ATI gene. Nucleotide sequence analysis revealed that the upstream region of the coding frame contained a sequence closely resembling the VV late promoter consensus sequence and that the gene encoded a protein of Mr 150,000.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2826668     DOI: 10.1099/0022-1317-69-1-35

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  35 in total

1.  Genome-wide analysis of vaccinia virus protein-protein interactions.

Authors:  S McCraith; T Holtzman; B Moss; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases.

Authors:  G L Smith; Y S Chan; S M Kerr
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

3.  Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses.

Authors:  Karen Baur; Kay Brinkmann; Marc Schweneker; Juliane Pätzold; Christine Meisinger-Henschel; Judith Hermann; Robin Steigerwald; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

4.  Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells.

Authors:  Shu-Jung Chang; Yu-Xun Chang; Roza Izmailyan; Yin-Liang Tang; Wen Chang
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

5.  Increased expression in vivo and in vitro of foreign genes directed by A-type inclusion body hybrid promoters in recombinant vaccinia viruses.

Authors:  S Funahashi; S Itamura; H Iinuma; K Nerome; M Sugimoto; H Shida
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

6.  The vaccinia virus 4c and A-type inclusion proteins are specific markers for the intracellular mature virus particle.

Authors:  D Ulaeto; D Grosenbach; D E Hruby
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Congregation of orthopoxvirus virions in cytoplasmic A-type inclusions is mediated by interactions of a bridging protein (A26p) with a matrix protein (ATIp) and a virion membrane-associated protein (A27p).

Authors:  Amanda R Howard; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

8.  Formation of orthopoxvirus cytoplasmic A-type inclusion bodies and embedding of virions are dynamic processes requiring microtubules.

Authors:  Amanda R Howard; Bernard Moss
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

9.  Naturally occurring orthopoxviruses: potential for recombination with vaccine vectors.

Authors:  T Sandvik; M Tryland; H Hansen; R Mehl; U Moens; O Olsvik; T Traavik
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.

Authors:  H Shida; Y Hinuma; M Hatanaka; M Morita; M Kidokoro; K Suzuki; T Maruyama; F Takahashi-Nishimaki; M Sugimoto; R Kitamura
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.